|
AEBP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.744120E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.539200E-03 |
| Normal-vs-Stage2 |
1.582290E-02 |
| Normal-vs-Stage3 |
2.800000E-03 |
| Normal-vs-Stage4 |
2.169400E-04 |
| Stage1-vs-Stage2 |
6.361800E-01 |
| Stage1-vs-Stage3 |
4.660400E-01 |
| Stage1-vs-Stage4 |
7.588100E-02 |
| Stage2-vs-Stage3 |
9.566600E-01 |
| Stage2-vs-Stage4 |
3.047600E-01 |
| Stage3-vs-Stage4 |
2.490000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.556690E-03 |
| Normal-vs-AfricanAmerican |
5.943800E-01 |
| Normal-vs-Asian |
1.069740E-02 |
| Caucasian-vs-AfricanAmerican |
2.274800E-01 |
| Caucasian-vs-Asian |
9.798400E-01 |
| AfricanAmerican-vs-Asian |
2.523800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.005300E-04 |
| Normal-vs-Female |
6.041500E-03 |
| Male-vs-Female |
1.895220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.106100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.038200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.019390E-03 |
| Normal-vs-Age(81-100Yrs) |
6.067800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.512400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.414570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.234200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.880200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.201800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.072400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.128830E-01 |
| Classical-VS-Follicular |
6.164600E-03 |
| Classical-VS-Other |
5.480400E-01 |
| Classical-VS-Normal |
3.131700E-02 |
| Tall-VS-Follicular |
8.368400E-01 |
| Tall-VS-Other |
8.174800E-01 |
| Tall-VS-Normal |
5.217700E-03 |
| Follicular-VS-Other |
7.627800E-01 |
| Follicular-VS-Normal |
4.759700E-04 |
| Other-VS-Normal |
1.676180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.384200E-04 |
| Normal-vs-N1 |
1.939440E-03 |
| N0-vs-N1 |
7.782800E-01 |
|
|
